BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28833364)

  • 1. Eosinophilia secondary to lenalidomide therapy.
    Escudero-Vilaplana V; Osorio-Prendes S; Collado-Borrell R; González-Arias E; Sanjurjo-Sáez M
    J Clin Pharm Ther; 2018 Apr; 43(2):273-275. PubMed ID: 28833364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lenalidomide and dexamethasone in patients with POEMS syndrome: results of a prospective, open-label trial.
    Nozza A; Terenghi F; Gallia F; Adami F; Briani C; Merlini G; Giordano L; Santoro A; Nobile-Orazio E
    Br J Haematol; 2017 Dec; 179(5):748-755. PubMed ID: 29048107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lenalidomide as frontline therapy in polyneuropathy, organomegaly, endocrinopathy, monoclonal protein and skin changes syndrome: a retrospective case series of eight patients.
    Lestang E; Caristan A; Néel A; Graveleau J; Duhamel E; Masseau A; Connault J; Maisonneuve H; Le Gouill S; Blin N; Touzeau C; Moreau P; Hamidou M
    Leuk Lymphoma; 2015 Jun; 56(6):1895-6. PubMed ID: 25347429
    [No Abstract]   [Full Text] [Related]  

  • 4. Lenalidomide in patients with POEMS syndrome: a systematic review and pooled analysis.
    Zagouri F; Kastritis E; Gavriatopoulou M; Sergentanis TN; Psaltopoulou T; Terpos E; Dimopoulos MA
    Leuk Lymphoma; 2014 Sep; 55(9):2018-23. PubMed ID: 24295131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of sexual function in POEMS syndrome after combination therapy of Lenalidomide and dexamethasone.
    Yang H; Huang X; Cai Q; Wang C; Cao X; Zhou D; Li J
    Orphanet J Rare Dis; 2016 Jun; 11(1):80. PubMed ID: 27317315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of lenalidomide on rare blood disorders: Langerhans cell histiocytosis, multicentric Castleman disease, POEMS syndrome, Erdheim-Chester disease and angiomatosis].
    Adam Z; Pour L; Krejčí M; Zahradová L; Szturz P; Koukalová R; Rehák Z; Nebeský T; Hájek R; Král Z; Mayer J
    Vnitr Lek; 2012 Nov; 58(11):856-66. PubMed ID: 23256832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lenalidomide-Induced Ischemic Cerebrovascular Disease in Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome.
    Mitsutake A; Matsumoto H; Hatano K; Irie K; Tsukada N; Hashida H
    J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):e102-e103. PubMed ID: 29395638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lenalidomide Treatment for Thalidomide-refractory POEMS Syndrome: A Prospective Single-arm Clinical Trial.
    Suichi T; Misawa S; Nagashima K; Sato Y; Iwai Y; Katayama K; Sekiguchi Y; Shibuya K; Amino H; Suzuki YI; Tsuneyama A; Nakamura K; Kuwabara S
    Intern Med; 2020 May; 59(9):1149-1153. PubMed ID: 32009091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of POEMS syndrome with lenalidomide and dexamethasone].
    Goto A; Iyama S; Sugama Y; Yoshida M; Ibata S; Tatekoshi A; Fujita C; Kikuchi S; Ikeda H; Murase K; Takada K; Kato J; Kobune M
    Rinsho Ketsueki; 2019; 60(4):308-313. PubMed ID: 31068561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete remission with a combination of lenalidomide, cyclophosphamide and prednisolone in a patient with incomplete POEMS syndrome.
    Suyanı E; Yağcı M; Sucak GT
    Acta Haematol; 2011; 126(4):199-201. PubMed ID: 21849771
    [No Abstract]   [Full Text] [Related]  

  • 11. [POEMS syndrome treated with lenalidomide plus high-dose dexamethasone as a pre-transplant induction therapy].
    Matsuura S; Ogusa E; Taguchi J; Imai N; Fujita H; Tomita N; Ishigatsubo Y; Fujisawa S
    Rinsho Ketsueki; 2012 Dec; 53(12):2025-8. PubMed ID: 23318971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation.
    Vannata B; Laurenti L; Chiusolo P; Sorà F; Balducci M; Sabatelli M; Luigetti M; Giannotta C; De Stefano V; Leone G; Sica S
    Am J Hematol; 2012 Jun; 87(6):641-2. PubMed ID: 22488443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lenalidomide therapy in a rare case of POEMS syndrome with kappa restriction.
    Sethi S; Tageja N; Arabi H; Penumetcha R
    South Med J; 2009 Oct; 102(10):1092-3. PubMed ID: 19738540
    [No Abstract]   [Full Text] [Related]  

  • 14. [Successful treatment of POEMS syndrome-associated pulmonary hypertension with lenalidomide and dexamethasone therapy].
    Nakamura D; Hayashida M; Kubota K; Matsuura E; Tabuchi T; Arima N; Inoue H; Yoshimitsu M; Ishitsuka K
    Rinsho Ketsueki; 2018; 59(5):489-491. PubMed ID: 29877235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of myeloma-induced ICOS-L and regulatory T cell generation by lenalidomide and dexamethasone therapy.
    Scott GB; Carter C; Parrish C; Wood PM; Cook G
    Cell Immunol; 2015 Sep; 297(1):1-9. PubMed ID: 26051632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of lenalidomide in POEMS syndrome: a retrospective study of 20 patients.
    Royer B; Merlusca L; Abraham J; Musset L; Haroche J; Choquet S; Leleu X; Sebban C; Decaux O; Galicier L; Roussel M; Recher C; Banos A; Guichard I; Brisseau JM; Godmer P; Hermine O; Deplanque G; Facon T; Asli B; Leblond V; Fermand JP; Marolleau JP; Jaccard A
    Am J Hematol; 2013 Mar; 88(3):207-12. PubMed ID: 23335406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalidomide and lenalidomide in primary myelofibrosis.
    Holle N; de Witte T; Mandigers C; Schaap N; Raymakers R
    Neth J Med; 2010 Aug; 68(1):293-8. PubMed ID: 20739725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalidomide reduces serum VEGF levels and improves peripheral neuropathy in POEMS syndrome.
    Kuwabara S; Misawa S; Kanai K; Sawai S; Hattori T; Nishimura M; Nakaseko C
    J Neurol Neurosurg Psychiatry; 2008 Nov; 79(11):1255-7. PubMed ID: 18469028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lenalidomide in combination with vorinostat and dexamethasone for the treatment of relapsed/refractory peripheral T cell lymphoma (PTCL): report of a phase I/II trial.
    Hopfinger G; Nösslinger T; Lang A; Linkesch W; Melchardt T; Weiss L; Egle A; Greil R
    Ann Hematol; 2014 Mar; 93(3):459-62. PubMed ID: 24441915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thalidomide in POEMS syndrome: case report.
    Sinisalo M; Hietaharju A; Sauranen J; Wirta O
    Am J Hematol; 2004 May; 76(1):66-8. PubMed ID: 15114600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.